Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and ...

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and ...

BioArctic’s global license agreement with Bristol Myers Squibb for PyroGlu-Aß antibody programme effective after antitrust clearance and closing: Stockholm, Sweden Saturday, Fe ...

Jaime Bortz, 39, is losing her memory to dementia. Her mom, now a full-time carer, is foreshadowing the burden many families ...

PITTSBURGH, PA, USA I February 20, 2025 I Myris Therapeutics™ emerged from stealth today to announce its strategic focus. Myris, formerly known as ...

Imagine a cancer treatment that precisely targets malignant cells, leaving healthy ones untouched. Consider, also, a cancer treatment that corrects abnormal protein synthesis to produce healthy ...

Bits of viral genes incorporated into human DNA have been linked to cancer, ALS and schizophrenia. But many of these genes may not be harmful, and could even protect against infectious disease.

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes.

Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy.

Nestled in the lap of the Himalayas and blessed with lush biodiversity, India’s North East Region (NER) is a land of hidden treasures. Its vibrant landscapes, rich culture, and vast  pool of resources ...

By Sunita Sohrabji The abrupt shutdown of USAID-funded projects has sent shockwaves through the global health community, with experts warning of severe consequences for disease research, vaccine ...